Bumi Teknokultura Unggul Tbk vs Merck Tbk. — how do they compare? Bumi Teknokultura Unggul Tbk trades at Rp11 (market cap 462.77B, 11.31M 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 24.6K 24h volume). The key difference: Merck Tbk. is far larger — about 3.7× Bumi Teknokultura Unggul Tbk's market cap, and Bumi Teknokultura Unggul Tbk is more actively traded (11.31M versus 24.6K). Which is the better fit depends on your goals.
| BTEK | MERK | |
|---|---|---|
Market Cap | 462.77B | 1.7T |
Volume | 11.31M | 24.6K |
Lot | 113.09K | 246 |
Turnover | 124.4M | 94.38M |
Average Price | 11 | 3,836.59 |
Value | 124.4M | 94.38M |
Indicative Equilibrium Price | 11 | 3,850 |
Indicative Equilibrium Volume | 328.36K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bumi Teknokultura Unggul Tbk (the Company) was established based on notarial deed No.12 dated June 6, 2001 of Rusman, SH., notary in Jakarta. The Minister of Justice of the Republic of Indonesia approved the deed of establishment in his decision dated April 23, 2002 and was published in the State Gazette of the Republic of Indonesia No.80 Supplement No.9565 dated Oct 7, 2003. The latest changes in the articles of association of the Company was based on notarial deed No.51 dated October 21, 2003 of Rini Yulianti SH, notary in Jakarta, regarding with public offering.
Read more on BTEK →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →